PYPD — PolyPid Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1611842 ·
Last close
$6.54
Market Cap
$132.84M
52W High
$7.15
52W Low
$3.50
ADV30
173,509
Next earnings
2027-02-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -8,470,000 | -5,754,000 | 40,120,000 | 5,414,000 | 36,219,000 |
| Jun 2026 | 0 | — | -7,849,000 | -7,849,000 | 15,234,000 | 6,563,000 | 9,846,000 |
| Mar 2026 | 0 | — | -7,760,000 | -7,728,000 | 19,160,000 | 8,888,000 | 10,380,000 |
| Dec 2025 | 0 | — | -8,530,000 | -8,473,000 | 22,307,000 | 6,402,000 | 11,334,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-317,077,000
Inventory
$1,359,000
Receivables
—
ST Investments
$0
EBIT TTM
$-31,917,000
Pretax Income TTM
$-31,554,000
Interest Exp TTM
$1,199,000
Analysts
5
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -32,967,000 | -34,169,000 | 22,307,000 | 11,334,000 | 10,973,000 | -27,879,000 |
| Dec 2024 | 0 | -28,029,000 | -29,022,000 | 25,220,000 | 17,536,000 | 7,684,000 | -21,963,000 |
| Dec 2023 | 0 | -22,867,000 | -23,865,000 | 15,372,000 | 17,468,000 | -2,096,000 | -17,236,000 |
| Dec 2022 | 0 | -38,888,000 | -39,557,000 | 25,971,000 | 20,142,000 | 5,829,000 | -34,317,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.23
Max Pain — expiry 2027-02-19
max pain strike: $5.00 · spot: $6.56 · call oi: 3,681 · put oi: 294Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FOCL | EDAP TMS SA | $134.10M | $2.84 | — |
| TLSI | TriSalus Life Sciences, Inc. | $141.60M | $2.30 | — |
| INGN | Inogen Inc | $147.82M | $5.68 | — |
| LUNG | Pulmonx Corp | $119.11M | $2.73 | — |
| KRMD | KORU Medical Systems, Inc. | $151.38M | $3.49 | — |
News headlines (Yahoo Finance, 1h cache)
PolyPid: 3 Key Takeaways for Long-Term Investors
2026-11-11 22:27 · Yahoo
PolyPid Ltd. Q3 2026 Earnings Call Summary
2026-11-11 22:16 · Yahoo
PolyPid (PYPD) Q3 2026 Earnings Call Transcript
2026-11-11 22:12 · Yahoo
PolyPid Ltd (PYPD) Q3 2026 Earnings Call Highlights: D-PLEX100 Nears FDA Decision as Azurity ...
2026-11-11 21:06 · Yahoo
What PolyPid (PYPD) Said on Its Q3 Earnings Call
2026-11-11 15:15 · Yahoo
PolyPid Provides Corporate Update and Reports Third Quarter 2026 Financial Results
2026-11-11 12:30 · Yahoo
PolyPid to Report Third Quarter 2026 Financial Results and Operational Highlights on November 11, 2026
2026-10-29 12:00 · Yahoo
PolyPid Targets 2027 D-PLEX100 Launch, Unveils Diabetic Foot Infection Program
2026-10-29 11:02 · Yahoo
PolyPid Unveils Expanded Pipeline Strategy, Introducing PD01B, a New Kynatrix™ Based Product Candidate for the Treatment of Diabetic Foot Infections
2026-10-28 12:00 · Yahoo
PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026
2026-10-15 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.